» Articles » PMID: 10540359

Immunocytochemical Localization of Cannabinoid CB1 Receptor and Fatty Acid Amide Hydrolase in Rat Retina

Overview
Journal J Comp Neurol
Specialty Neurology
Date 1999 Dec 14
PMID 10540359
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Cannabinoids have major effects on central nervous system function. Recent studies indicate that cannabinoid effects on the visual system have a retinal component. Immunocytochemical methods were used to localize cannabinoid CB1 receptor immunoreactivity (CB1R-IR) and an endocannabinoid (anandamide and 2-arachidonylglycerol) degradative enzyme, fatty acid amide hydrolase (FAAH)-IR, in the rat retina. Double labeling with neuron-specific markers permitted identification of cells that were labeled with CB1R-IR and FAAH-IR. CB1R-IR was observed in all cells that were protein kinase C-immunoreactive (rod bipolar cells and a subtype of GABA-amacrine cell) as well as horizontal cells (identified by calbindin-IR). There was also punctate CB1R-IR in the distal one-third of the inner plexiform layer (IPL) that could not be assigned to a cell type. FAAH-IR was most prominent in large ganglion cells, whose dendrites projected to a narrow band in the proximal IPL. Weaker FAAH-IR was observed in the soma of horizontal cells (identified by calbindin-IR); the soma of large, but not small, dopamine amacrine cells (identified by tyrosine hydroxylase-IR); and dendrites of orthotopic- and displaced-starburst amacrine cells (identified by choline acetyltransferase-IR) but in less than 50% of the starburst amacrine cell somata. The extensive distribution of CB1R-IR on horizontal cells and rod bipolar cells indicates a role of endocannabinoids in scotopic vision, whereas the more widespread distribution of FAAH-IR indicates a complex control of endocannabinoid release and degradation in the retina.

Citing Articles

Non-canonical type 1 cannabinoid receptor signaling regulates night visual processing in the inner rat retina.

Estay S, Morales-Moraga C, Vielma A, Palacios-Munoz A, Chiu C, Chavez A iScience. 2024; 27(6):109920.

PMID: 38799553 PMC: 11126983. DOI: 10.1016/j.isci.2024.109920.


CB1 Cannabinoid Receptor is a Target for Neuroprotection in Light Induced Retinal Degeneration.

Solino M, Larrayoz I, Lopez E, Rey-Funes M, Bareiro M, Loidl C Adv Drug Alcohol Res. 2024; 2:10734.

PMID: 38390616 PMC: 10880786. DOI: 10.3389/adar.2022.10734.


Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.

Papadogkonaki S, Spyridakos D, Lapokonstantaki E, Chaniotakis N, Makriyannis A, Malamas M Int J Mol Sci. 2023; 24(21).

PMID: 37958673 PMC: 10650178. DOI: 10.3390/ijms242115689.


Cell-autonomous and differential endocannabinoid signaling impacts the development of presynaptic retinal ganglion cell axon connectivity .

Del Rio Jr R, Serrano R, Gomez E, Martinez J, Edward M, Santos R Front Synaptic Neurosci. 2023; 15:1176864.

PMID: 37252636 PMC: 10213524. DOI: 10.3389/fnsyn.2023.1176864.


Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.

Spyridakos D, Mastrodimou N, Vemuri K, Ho T, Nikas S, Makriyannis A Int J Mol Sci. 2023; 24(1).

PMID: 36613692 PMC: 9820336. DOI: 10.3390/ijms24010240.